NIH Weekly Funding Opportunities and Policy Notices

Monday, December 17, 2018 - 6:31am
Notice NOT-DK-19-005 from the NIH Guide for Grants and Contracts
Monday, December 17, 2018 - 1:16am
Funding Opportunity RFA-OD-19-014 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) to establish 5 new awards for the Research Evaluation and Commercialization Hubs (REACH) program to address the problems that hinder the critical, early steps necessary to translate novel scientific advances and discoveries into commercially viable diagnostics, devices, therapeutics, and tools that improve patient care and advance public health. The five awardees will participate in a technology development consortium that incorporates best practices from current pilot programs and fulfills the objectives of the Phase 0 Proof of Concept Partnership pilot program, in accordance with Section 5127 of the 2011 SBIR/STTR Reauthorization Act (P.L. 112-81) and reauthorized through FY 2022 within H.R. 5515 Sec 854. The REACH program advances FY2020 Administration Research and Development Budget Priorities, including educating and training a workforce for the 21st century economy, transferring technology from the laboratory to the marketplace, and partnering with industry and academia to advance the RandD enterprise.
Friday, December 14, 2018 - 8:26am
Funding Opportunity PAR-19-104 from the NIH Guide for Grants and Contracts. As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. Whole genome, exome, and transcriptome sequencing may be available for tumor or affected tissue when justified. These data will become part of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource) for the pediatric research community.
Friday, December 14, 2018 - 1:12am
Funding Opportunity RFA-HD-19-023 from the NIH Guide for Grants and Contracts. The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success, and also behavioral and social science research projects to study contraceptive use and non-use of marketed products or products in clinical development. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Thursday, December 13, 2018 - 9:29am
Notice NOT-NS-19-025 from the NIH Guide for Grants and Contracts
Thursday, December 13, 2018 - 9:22am
Notice NOT-AR-19-031 from the NIH Guide for Grants and Contracts
Wednesday, December 12, 2018 - 9:01am
Notice NOT-NR-18-024 from the NIH Guide for Grants and Contracts
Wednesday, December 12, 2018 - 8:34am
Notice NOT-NR-18-022 from the NIH Guide for Grants and Contracts
Wednesday, December 12, 2018 - 8:15am
Notice NOT-OD-19-043 from the NIH Guide for Grants and Contracts
Wednesday, December 12, 2018 - 8:10am
Funding Opportunity RFA-DE-19-007 from the NIH Guide for Grants and Contracts. The purpose of the program is to support mentoring and research education activities that enhance the diversity of the NIDCR research workforce by establishing long-term mentoring that will enable junior investigators who are underrepresented in the biomedical, behavioral and clinical sciences to develop a research program and obtain NIDCR funding
Wednesday, December 12, 2018 - 8:10am
Funding Opportunity PAR-19-100 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from two or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA. The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, and collaborative research projects in the CTSA Program, with the goal of assessing utility and feasibility of proposed innovation(s).
Wednesday, December 12, 2018 - 8:10am
Funding Opportunity PAR-19-099 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from three or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA.
Wednesday, December 12, 2018 - 7:27am
Funding Opportunity PAR-19-102 from the NIH Guide for Grants and Contracts. The goal of the Graduate Research Initiative for Student Enhancement (G-RISE) program is to develop a diverse pool of scientists earning a Ph.D., who have the skills to successfully transition into careers in the biomedical research workforce. This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. This program is limited to applications from training programs at research-active institutions (i.e., those with a 3-year average of NIH Research Project Grant funding less than $7.5 million total costs).
Wednesday, December 12, 2018 - 7:07am
Funding Opportunity PAR-19-101 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U01 cooperative agreement applications for Physical Science-Oncology Projects (PS-OP). The goal of the PS-OPs is to foster the convergence of physical sciences approaches and perspectives with cancer research to advance our understanding of cancer biology and oncology by forming small transdisciplinary teams of physical scientists and cancer biologists/physician-scientists. Examples of physical scientists may include engineers, physicists, mathematicians, chemists, and computer scientists. The PS-OPs, individually and as a collaborative Network along with other PS-OPs and the Physical Sciences-Oncology Centers (PS-OC), will support transdisciplinary research that: (1) establishes a physical sciences perspective within the cancer research community; (2) facilitates team science and field convergence at the intersection of physical sciences and cancer research; and (3) collectively tests physical sciences-based experimental and theoretical concepts of cancer and promotes innovative solutions to address outstanding questions in cancer research.
Wednesday, December 12, 2018 - 6:14am
Notice NOT-OD-19-045 from the NIH Guide for Grants and Contracts
Wednesday, December 12, 2018 - 5:58am
Notice NOT-NS-19-023 from the NIH Guide for Grants and Contracts

Pages